Literature DB >> 22608531

Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.

Chia-Hung Liao1, Chih-Yu Chi, Yi-Jen Wang, Shu-Wen Tseng, Chia-Huei Chou, Cheng-Mao Ho, Po-Chang Lin, Mao-Wang Ho, Jen-Hsian Wang.   

Abstract

BACKGROUND AND
PURPOSE: Cryptococcus species are the most common causative agents of fungal meningitis. Different populations may show different clinical manifestations and outcomes. In this retrospective study, we investigated these differences in patients with and without HIV infection.
METHODS: From 1995 to 2009, we collected data from HIV-infected or HIV-uninfected patients aged 18 years or over who had cryptococcal meningitis (CM) in a medical center in Taiwan. We reviewed and analyzed their demographic data, clinical manifestations, therapeutic strategies and outcomes.
RESULTS: Among the 72 patients with CM, 19 HIV-infected patients were predominantly younger males, and all of them had AIDS status when CM was diagnosed. In contrast, the 53 HIV-uninfected patients were mostly older males with underlying diseases. The time from initial symptoms to diagnosis was shorter in HIV-infected patients (median 10 vs. 18 days, p = 0.048). The HIV-infected patients presented with less pleocytosis (p = 0.003) and lower protein levels in the cerebrospinal fluid (CSF), but a higher proportion had positive results for cryptococci in the CSF (90% vs. 60%, p = 0.02) and blood (53% vs. 21%, p = 0.009) cultures. Surgical drains and repeated lumbar punctures for the management of increased intracranial pressure were performed in 47% of the HIV-infected patients and 38% of the HIV-uninfected patients. A lower mortality rate was observed in the HIV-infected patients (p = 0.038). On multivariate analysis, initial CD4 count ≤20/mm(3) was an indicator of death or relapse in HIV-infected patients. In the HIV-uninfected group, the initial high cryptococcal antigen titer in the CSF (≥1:512) and hydrocephalus were related to unsatisfactory outcomes.
CONCLUSION: In addition to well-known differences, we found a lower mortality in HIV-infected patients than in HIV-uninfected patients. Cryptococci and inflammation in the central nervous system may play important roles in the pathogenesis of CM. Low intensity of inflammation and effective surgical CSF drains for increased intracranial pressure and cryptococci removal may contribute to lower mortality in HIV-infected patients.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608531     DOI: 10.1016/j.jmii.2011.12.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  29 in total

1.  Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.

Authors:  Joshua Rhein; Nathan C Bahr; Andrew C Hemmert; Joann L Cloud; Satya Bellamkonda; Cody Oswald; Eric Lo; Henry Nabeta; Reuben Kiggundu; Andrew Akampurira; Abdu Musubire; Darlisha A Williams; David B Meya; David R Boulware
Journal:  Diagn Microbiol Infect Dis       Date:  2015-12-01       Impact factor: 2.803

2.  Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era.

Authors:  Matthew A Hevey; Rachel M Presti; Jane A OʼHalloran; Lindsey Larson; Krunal Raval; William G Powderly; Andrej Spec
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

3.  Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness: A Retrospective Cohort Study.

Authors:  Matthew A Hevey; Ige A George; Krunal Raval; William G Powderly; Andrej Spec
Journal:  Am J Med       Date:  2019-05-08       Impact factor: 4.965

Review 4.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

5.  Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient.

Authors:  Sophie Gough; Scott Borgetti; Christopher R Fernandes
Journal:  IDCases       Date:  2022-07-11

6.  Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Authors:  I N Hakyemez; H Erdem; G Beraud; M Lurdes; A Silva-Pinto; C Alexandru; B Bishop; F Mangani; X Argemi; M Poinot; R Hasbun; M Sunbul; M Akcaer; S Alp; T Demirdal; K Angamuthu; F Amer; E Ragab; G A Shehata; D Ozturk-Engin; N Ozgunes; L Larsen; S Zimmerli; O R Sipahi; E Tukenmez Tigen; G Celebi; N Oztoprak; A C Yardimci; Y Cag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-08       Impact factor: 3.267

7.  A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset.

Authors:  H Zheng; Q Chen; Z Xie; D Wang; M Li; X Zhang; Y Man; J Lao; N Chen; L Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-20       Impact factor: 3.267

8.  Comparative Epidemiology and Outcomes of Human Immunodeficiency virus (HIV), Non-HIV Non-transplant, and Solid Organ Transplant Associated Cryptococcosis: A Population-Based Study.

Authors:  Ige A George; Andrej Spec; William G Powderly; Carlos A Q Santos
Journal:  Clin Infect Dis       Date:  2018-02-01       Impact factor: 9.079

9.  Clinical Aspects of Immune Damage in Cryptococcosis.

Authors:  Seher Anjum; Peter R Williamson
Journal:  Curr Fungal Infect Rep       Date:  2019-07-22

10.  Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status.

Authors:  Kyle D Brizendine; John W Baddley; Peter G Pappas
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.